Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Oncopeptides AB

ONCO
Current price
1.5 SEK -0.042 SEK (-2.73%)
Last closed 1.54 SEK
ISIN SE0009414576
Sector Healthcare
Industry Biotechnology
Exchange Stockholm Exchange
Capitalization 330 029 327 SEK
Yield for 12 month -69.88 %
1Y
3Y
5Y
10Y
15Y
ONCO
21.11.2021 - 28.11.2021

Oncopeptides AB (publ), a biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally. Its lead product candidate is Pepaxti (melflufen), a drug conjugate for the treatment of relapsed refractory multiple myeloma in adult patients. The company also engages in the research for small popypeptide based killer engages for the treatment of RRMM and hematological or solid tumors; and other peptide-drug conjugates for glioblastoma and hematological or solid tumors. Oncopeptides AB (publ) was incorporated in 2000 and is headquartered in Stockholm, Sweden Address: Luntmakargatan 46, Stockholm, Sweden, 111 37

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

57.15 SEK

P/E ratio

Dividend Yield

Current Year

+35 773 387 SEK

Last Year

+8 486 272 SEK

Current Quarter

+8 283 136 SEK

Last Quarter

+5 151 692 SEK

Current Year

+36 869 343 SEK

Last Year

+8 480 182 SEK

Current Quarter

+7 321 249 SEK

Last Quarter

+4 860 186 SEK

Key Figures ONCO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -257 865 977 SEK
Operating Margin TTM -898.23 %
PE Ratio
Return On Assets TTM -39.64 %
PEG Ratio
Return On Equity TTM -141.97 %
Wall Street Target Price 57.15 SEK
Revenue TTM 21 704 756 SEK
Book Value 0.61 SEK
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -68.6 %
Dividend Yield
Gross Profit TTM 8 480 182 SEK
Earnings per share -1.75 SEK
Diluted Eps TTM -1.75 SEK
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ONCO

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ONCO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 3574:2547
Payout Ratio
Last Split Date 16.04.2024
Dividend Date

Stock Valuation ONCO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 2.5666
Price Sales TTM 15.2054
Enterprise Value EBITDA -1.549
Price Book MRQ 1.6751

Financials ONCO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ONCO

For 52 weeks

1.51 SEK 9.55 SEK
50 Day MA 2.13 SEK
Shares Short Prior Month
200 Day MA 3.5 SEK
Short Ratio
Shares Short
Short Percent